Comparison

NYP Advances vs COAPT Risk Score

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

NYP Advances

Access the latest heart failure updates, expert reviews of clinical trials, and insights into ongoing research. Stay informed about breakthroughs in treatment from world-class doctors at NewYork-Presbyterian.

Highlights
  • Heart failure updates
  • Clinical trial reviews
  • Heart failure conference series
  • Ongoing research insights
  • Breakthroughs in treatment
Features
Read full description

NYP Advances brings together the latest updates in heart failure with expert reviews of clinical trials that have shaped the field, our state-of-the-art heart failure conference series, as well as insight into ongoing heart failure research at NYP, all available at your fingertips. Stay up-to-date on breakthroughs in the treatment of heart failure through the innovative work being led by the teams at NewYork-Presbyterian, with world-class doctors from Columbia and Weill Cornell Medicine. NewYork-Presbyterian is a top hospital per U.S. News & World Report (2024-2025).

About

COAPT Risk Score

This medical tool calculates a 2-year risk score for death and/or heart failure hospitalization in patients with specific heart conditions. It combines clinical and echocardiographic data to aid in shared decision-making regarding treatment options.

Highlights
  • Risk prediction for death and heart failure hospitalization
  • Calculates 2-year risk score
  • Combines clinical and echocardiographic variables
  • Supports shared decision-making
  • Educational tool for medical professionals
  • Based on COAPT trial data
Features
Read full description

For educational purposes and for use by medical professionals only. For patients with severe functional mitral regurgitation and symptomatic heart failure (left ventricular ejection fraction between 20-50%) despite best medical therapy. The COAPT Risk Score is a simple risk prediction tool created by combining clinical and echocardiographic variables in patients with heart failure (HF) and moderate-to-severe or severe functional mitral regurgitation (FMR) who remain symptomatic despite maximally tolerated guideline directed medical therapy (GDMT). The COAPT Risk Score provides valuable prognostic information regarding the 2-year risk of death and/or heart failure hospitalization (HFH). The score is derived from the COAPT trial population of patients with HF and moderate-to-severe or severe FMR randomized to treatment with either transcatheter edge-to-edge repair (TEER) with MitraClip plus GDMT or GDMT alone. We can incorporate TEER in the risk score and provide updated 2-year risk of death and/or HFH which can serve as a valuable shared decision-making tool for patients and physicians as well as heart teams while deciding about TEER. Created by a team of subject-matter experts including: the director of The Mount Sinai Hospital cardiac cath lab Dr. Kini, Director of Clinical and Interventional Cardiology at the Mount Sinai Health System Dr Sharma, the Mount Sinai Hospital Surgical Director Dr. Tang, COAPT Principal Investigator Dr. Stone, and COAPT Risk Score publication author Dr. Shah.

Screenshots

NYP Advances4 screens
COAPT Risk Score4 screens

Verdict

The call

The clearest difference is ratings volume: NYP Advances at 23 against COAPT Risk Score's 1. COAPT Risk Score's advantage is iOS requirement (12.0 vs 16.0). On price, rating, ads and in-app purchases there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

ReceptionRating · Positive reviews · Number of ratings

On the App Store both sit at effectively the same score — 5.0 for NYP Advances against 5.0 for COAPT Risk Score. That said, the two scores are not equally well evidenced: NYP Advances has 23 ratings behind it against 1, so its average is the more settled of the two.

Scorecard2 real differences · 8 level
NYP Advances versus COAPT Risk Score: the parameters behind the verdict, then further details
ParameterNYP AdvancesCOAPT Risk Score
PriceFreeFree
Rating5.0 (23 ratings)5.0 (1 ratings)
Positive reviews100.0% of reviews—
Number of ratings23 — better1
Update frequencyEvery 2 months—
AdsNoNo
In-app purchasesNoNo
MonetizationFreeFree
DevicesiPhone, iPadiPhone, iPad, iPod — better
Requires iOS16.012.0 — better
Further details — not scored
Size53 MB28 MB
Age rating17+17+
DeveloperNewYork-Presbyterian HospitalCardiology Apps LLC

Customer experience

NYP Advances

All ratings22 ratings
Positive100.0%
Neutral0.0%
Negative0.0%
Written reviews12 reviews
Positive100.0%
Neutral0.0%
Negative0.0%

COAPT Risk Score

All ratings1 ratings
Positive100.0%
Neutral0.0%
Negative0.0%

In-app purchases

None

NYP Advances

No in-app purchases

None

COAPT Risk Score

No in-app purchases

Questions

Is NYP Advances free?
NYP Advances is free to download, with no in-app purchases.
Is COAPT Risk Score free?
COAPT Risk Score is free to download, with no in-app purchases.
Which has better reviews, NYP Advances or COAPT Risk Score?
NYP Advances and COAPT Risk Score are both rated 5.0 out of 5 on the App Store, from 23 and 1 ratings respectively.
Do NYP Advances or COAPT Risk Score have ads?
Neither NYP Advances nor COAPT Risk Score shows ads.

Other comparisons